Market Data
News
Tools
Markets
Discover
Subscribe Login/Register
S&P ASX 200
7,129.80
(
0.27%
)
S&P ASX All Technology
2,407.40
(
0.7%
)
Brent Oil
74.465
(
0.19%
)
US Dollar vs AUD
1.5163
(
-0.26%
)
Bitcoin
26,975.79
(
0.57%
)
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. X4 Pharmaceuticals Inc (XFOR)

  7. X4 Pharmaceuticals Inc (XFOR) News

XFOR

X4 Pharmaceuticals Inc

2.20
0.17 (8.37%)
Upgrade to Real-Time
Stock Name Stock Symbol Market Stock Type
X4 Pharmaceuticals Inc XFOR NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
Upgrade Icon
0.17 8.37% 2.20 09:56:07
Open Price Low Price High Price Close Price Previous Close
2.02 2.00 2.29 2.22 2.03
more quote information »

Recent News

Date Time Source Heading
02/6/202306:40EDGARSmall Company Offering and Sale of Securities Without..
02/6/202306:17EDGARCurrent Report Filing (8-k)
01/6/202305:42EDGARReport of Proposed Sale of Securities (144)
27/5/202305:05EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
05/5/202306:24EDGARQuarterly Report (10-q)
04/5/202323:06EDGARCurrent Report Filing (8-k)
04/5/202320:44EDGARCurrent Report Filing (8-k)
28/4/202306:27EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
26/4/202306:11EDGARProxy Statement (definitive) (def 14a)
22/3/202307:25EDGARAnnual Report (10-k)
21/3/202322:10EDGARCurrent Report Filing (8-k)
14/3/202307:53EDGARStatement of Changes in Beneficial Ownership (4)
14/3/202307:51EDGARStatement of Changes in Beneficial Ownership (4)
11/3/202308:06EDGARCurrent Report Filing (8-k)
16/2/202309:14EDGARStatement of Changes in Beneficial Ownership (4)
16/2/202309:14EDGARStatement of Changes in Beneficial Ownership (4)
16/2/202309:13EDGARStatement of Changes in Beneficial Ownership (4)
16/2/202309:12EDGARStatement of Changes in Beneficial Ownership (4)
15/2/202309:41EDGARAmended Statement of Ownership (sc 13g/a)
15/2/202308:35EDGARAmended Statement of Ownership (sc 13g/a)
15/2/202303:27EDGARAmended Statement of Ownership (sc 13g/a)
14/2/202322:35EDGARAmended Statement of Ownership (sc 13g/a)
14/2/202322:05EDGARAmended Statement of Ownership (sc 13g/a)
14/1/202300:03EDGARStatement of Ownership (sc 13g)
07/1/202309:27EDGARCurrent Report Filing (8-k)
06/1/202308:10EDGARCurrent Report Filing (8-k)
24/12/202208:03EDGARCurrent Report Filing (8-k)
20/12/202222:01EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
13/12/202206:35TRMNX4 Pharmaceuticals (XFOR) Receives a New Rating from..
10/12/202200:47EDGARCurrent Report Filing (8-k)
09/12/202222:04EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
07/12/202223:12TRMNX4 Pharma Tanks on Public Offering
07/12/202222:03EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
30/11/202223:35TRMNB.Riley Financial Keeps Their Buy Rating on X4..
30/11/202211:05TRMNBrookline Capital Markets Sticks to Its Buy Rating for X4..
10/11/202208:20EDGARCurrent Report Filing (8-k)
08/11/202213:07TRMNX4 Pharmaceuticals (XFOR) Receives a Buy from Stifel..
05/11/202207:21EDGARStatement of Changes in Beneficial Ownership (4)
05/11/202207:17EDGARInitial Statement of Beneficial Ownership (3)
04/11/202221:26TRMNX4 Pharmaceuticals (XFOR) Gets a Buy from H.C. Wainwright
04/11/202210:35TRMNBrookline Capital Markets Keeps Their Buy Rating on X4..
04/11/202207:20EDGARQuarterly Report (10-q)
04/11/202204:35TRMNB.Riley Financial Sticks to Their Buy Rating for X4..
03/11/202222:22EDGARCurrent Report Filing (8-k)
11/10/202222:35TRMNB.Riley Financial Remains a Buy on X4 Pharmaceuticals (XFOR)
28/9/202223:35TRMNH.C. Wainwright Sticks to Their Buy Rating for X4..
28/9/202202:15TRMNX4 Pharmaceuticals (XFOR) Receives a Buy from B.Riley..
28/9/202201:50TRMNAnalysts Offer Insights on Healthcare Companies: X4..
27/9/202221:54EDGARCurrent Report Filing (8-k)
20/8/202203:09EDGARStatement of Changes in Beneficial Ownership (4)
Your Recent History
NASDAQ
XFOR
X4 Pharmac..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: D: 20230602 02:22:40